It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Slickinfinity
My cousins 3 year old daughter takes cbd oil and she went from daily seizures to one a month if that at all. It works undoubtedly.
You would think that the DEA & friends would be more motivated to stop the flow of heroin from coming into this country through Mexico. All of that dope has got to be eating into big pharma's pain pill market.
originally posted by: underwerks
People forget it's against the law for the head of the DEA to even consider legalizing ANY substance that's already scheduled. Look it up.
Someone posted the law on that in a thread I made about Sessions as AG and his idiotic views on cannabis and prohibition. I had no idea.
For cannabis or anything else to be removed from scheduling would take a bi partisan effort from the majority of people in government and the population.
We aren't there yet. Most people in government still believe the lies about drugs and drug use simply because they've been lied to for so long. Tell a lie big enough and long enough and people will build their reality around it, and once that happens the truth is viewed as a lie.
originally posted by: FamCore
a reply to: ColdWisdom
You would think that the DEA & friends would be more motivated to stop the flow of heroin from coming into this country through Mexico. All of that dope has got to be eating into big pharma's pain pill market.
Do you realize that drugs like Narcan can be huge money makers for big pharma, being part of the reason the DEA and big pharma are cracking down on CBD rather than heroin?
How the Pharmaceutical Industry Is Making Money on Your Overdose
A recent review of FDA-approved clinical studies on the National Institute of Health website evaluated the safety and efficacy of herbal cannabis and completely refuted the contention by Rosenberg that cannabis has no medicinal value, concluding: “Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that Information on safety is lacking.”
NORML Deputy Director Paul Armentano released a statement regarding the DEA’s ill-advised decision stating:
For far too long, federal regulations have made clinical investigations involving cannabis needlessly onerous and have placed unnecessary and arbitrary restrictions on marijuana that do not exist for other controlled substances, including some other schedule I controlled substances.
While this announcement is a significant step toward better facilitating and expanding clinical investigations into cannabis’ therapeutic efficacy, ample scientific evidence already exists to remove cannabis from its schedule I classification and to acknowledge its relative safety compared to other scheduled substances, like opioids, and unscheduled substances, such as alcohol. Ultimately, the federal government ought to remove cannabis from the Controlled Substances Act altogether in a manner similar to alcohol and tobacco, thus providing states the power to establish their own marijuana regulatory policies free from federal intrusion.
Since the DEA has failed to take such action, then it is incumbent that members of Congress act swiftly to amend cannabis’ criminal status in a way that comports with both public and scientific opinion. Failure to do so continues the federal government’s ‘Flat Earth’ position; it willfully ignores the well-established therapeutic properties associated with the plant and it ignores the laws in 26* states recognizing marijuana’s therapeutic efficacy.
“The DEA’s decision is strictly a political one. There is nothing scientific about willful ignorance,” Armentano said.